DCAT Value Chain Insights

Biosimilars: Challenges and Opportunities in Market Uptake

Biosimilars represent a small part of the global pharmaceutical market with Europe leading in biosimilar approvals comparative to the US. What are the challenges and opportunities for biosimilar...

FDA Updates Investigations into Impurities in APIs

Earlier this month, FDA released results from its ongoing investigations of nitrosamine impurities in certain APIs, most recently ranitidine, and earlier “sartan”-containing APIs. What did the FDA...

A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More